Cannformatics, an early-stage biotechnology startup focused on personalizing medical cannabis treatment through the identification and application of saliva-based Cannabis-Responsive biomarkers, announced that Emmy Award winning television personality, medical cannabis advocate and entrepreneur Montel Williams has joined its advisory board. Williams will serve as a media and cannabis industry advisor to the company as it works to complete the final phase of research prior to launching its first commercial service for patients with autism spectrum disorder.
"Cannformatics' mission is to provide patients, with any medical condition treatable by cannabis, with the medical information they and their physicians need to improve health and quality of life. Montel, as both a medical cannabis patient and advocate has been on this mission for over twenty years. We are honored to have him join our advisory board," stated Cannformatics CEO and co-founder Dr. Itzhak Kurek. "Montel is joining the board at a perfect time as we prepare for the launch of our first commercial platform. We look forward to his advice and counsel as we ramp up outreach to patients, physicians, and the medical cannabis industry."
Williams is one of the highest profile advocates for medical cannabis in the country. He has used medical cannabis products to effectively manage the symptoms of his multiple sclerosis since his diagnosis with the disease in 1999. Williams is also the founder of Lenitiv Scientific LLC a cannabis product and branding company. In 2020 Williams launched his debut podcast Let's Be Blunt with Montel it was on that program where Williams met Dr. Kurek who was a guest on his show.
"For decades politicians, regulators, and much of the medical community have not just ignored medical cannabis they have contributed to the stigma patients face today. The science and data Cannformatics are developing cannot be ignored or dismissed. This company is quantifying the impact of cannabis on real patients, and I can't wait to help them tell their story," stated Williams.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo: Courtesy of Cannformatics
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.